Aijun Wang

Weekly reads: cats, COVID, CIRM, cancer stem cells, MS

diana farmer and aijun wang uc davis 1

There have been many other interesting scientific and specifically regenerative medicine developments and papers this past week including with CIRM and exciting CIRM funding to UC Davis so read on, but first a somewhat random question: are you more of a cat person or dog person? I’d say I’m both. But our big dog is …

Weekly reads: cats, COVID, CIRM, cancer stem cells, MS Read More »

3X recent stem cell & regenerative medicine good news

Stem cells spina bifida

In the past month or two there has been a steady stream of good news in the stem cell and regenerative medicine world. Here are three examples. Fate Therapeutics announced the first US IND for an induced pluripotent stem cell (IPSC)-related product. Its cleared product, FT500, is an off-the-shelf natural killer-based cancer immunotherapy. I expect …

3X recent stem cell & regenerative medicine good news Read More »

Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte

VC-01-post-implant-final1-e1503703572933, viacyte

It’s a difficult, but very important road to conclusively prove that an investigational stem cell therapy is both safe and effective in order to get final approval FDA or equivalents in other countries. For this reason, it is beneficial to highlight even small, but positive steps forward including encouraging pre-clinical data. Today I’m doing a …

Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte Read More »